POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	3d1n	POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 1 (Homo sapiens)	4 / 8	ASN I 256 PRO I 257 GLU I 254 PHE I 253	None	1.12A	18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	3d3l	ARACHIDONATE 12-LIPOXYGENASE, 12S-TYPE (Homo sapiens)	4 / 8	GLU A 650 TRP A 550 TRP A 647 TYR A 230	None	1.37A	13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	3kyd	SUMO-ACTIVATING ENZYME SUBUNIT 1 (Homo sapiens)	4 / 8	ASN A 168 GLU A 313 PHE A 154 TYR A 164	None None None EDO  A 347 (-4.6A)	1.25A	17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	3som	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE C PROTEIN (Homo sapiens)	4 / 8	PRO A  56 PHE A 154 TRP A 157 TYR A 205	None	1.47A	19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	4z0x	ANTIBODY HC26AM HEAVY CHAIN VARIABLE DOMAIN (Homo sapiens)	4 / 8	ASN B  56 PRO B  78 PHE B  76 TYR B 131	None	1.43A	21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	5hxb	PROTEIN CEREBLON (Homo sapiens)	4 / 8	ASN Z 351 PRO Z 352 TRP Z 380 TRP Z 400	85C  Z 502 (-3.6A) 85C  Z 502 (-4.4A) 85C  Z 502 (-3.2A) 85C  Z 502 (-3.7A)	0.76A	16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	5hxb	PROTEIN CEREBLON (Homo sapiens)	5 / 8	PRO Z 352 GLU Z 377 TRP Z 380 TRP Z 386 TRP Z 400	85C  Z 502 (-4.4A) 85C  Z 502 (-3.2A) 85C  Z 502 (-3.2A) 85C  Z 502 (-3.4A) 85C  Z 502 (-3.7A)	0.61A	16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	5ndz	LYSOZYME,PROTEINASE- ACTIVATED RECEPTOR 2,SOLUBLE CYTOCHROME B562,PROTEINASE-ACTI VATED RECEPTOR 2 (Escherichia coli; Homo sapiens; Escherichia virus T4)	4 / 8	ASN A 179 PRO A 180 GLU A2048 TRP A 175	None	1.48A	11.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_C_9UQC202_0 (CEREBLON ISOFORM 4)	6f1d	COMPLEMENT C1R SUBCOMPONENT (Homo sapiens)	4 / 8	PRO A 256 PHE A 250 TRP A 281 TYR A 197	None	1.35A	undetectable